文献速递脊柱关节炎

强直性脊柱炎与非放射学中轴型脊柱关节炎的亚临床动脉粥样硬化病变:806例多中心研究

Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients.
PubMed 文献 · Semin Arthritis Rheum · 2021-02-13

该多中心横断面研究比较了强直性脊柱炎(AS)与非放射学中轴型脊柱关节炎(nr-axSpA)患者的动脉粥样硬化负担,发现两组颈动脉斑块患病率和颈动脉内膜中层厚度(cIMT)在调整分析后无差异;基于颈动脉超声,AS和nr-axSpA中分别有10.7%和10.1%的低危患者、40.5%和45.5%的中危患者被重新分类为极高危;包含年龄、BASFI和ESR的模型在高特异性(88%)下识别出41%的中危axSpA患者为极高危。

要点

  • AS与nr-axSpA的亚临床动脉粥样硬化负担相似,颈动脉斑块和cIMT无显著差异。
  • 超过40%的SCORE中危axSpA患者经颈动脉超声重新分类为极高危。
  • 年龄、BASFI和ESR模型可高特异性识别中危患者中的极高危者。

核心结论

  • nr-axSpA与AS的动脉粥样硬化负担相似。
  • 颈动脉超声可使超过40%的SCORE中危axSpA患者重新分类为极高危。
  • 年龄、BASFI和ESR模型可识别41%的中危axSpA患者为极高危,特异性达88%。

研究设计与样本

  • 来自AtheSpAin队列的西班牙多中心横断面研究,纳入639例AS和167例nr-axSpA无心血管事件史患者。
  • 采用颈动脉超声测定cIMT和斑块,并应用SCORE评估心血管风险。

主要发现

  • AS患者较nr-axSpA患者年龄更大,心血管危险因素更多,C反应蛋白和ESR更高。
  • 调整分析后,两组颈动脉斑块患病率和cIMT无差异。
  • AS和nr-axSpA中因颈动脉斑块从低危重新分类为极高危的比例分别为10.7%和10.1%,从中危重新分类为极高危的比例分别为40.5%和45.5%。
  • 包含年龄、BASFI和ESR的模型在中危axSpA患者中识别出41%为极高危,特异性88%。

关键数值与推荐

  • 颈动脉超声检测斑块和cIMT;SCORE用于心血管风险评估。
  • AS与nr-axSpA低危重新分类为极高危比例:10.7% vs 10.1%;中危重新分类为极高危比例:40.5% vs 45.5%。
  • 年龄、BASFI和ESR模型识别中危患者中极高危的敏感性41%,特异性88%。

临床怎么用

  • 对axSpA患者应进行颈动脉超声评估亚临床动脉粥样硬化,尤其SCORE中危者。
  • 可考虑使用年龄、BASFI和ESR模型辅助识别中危患者中的极高危个体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare the atherosclerosis disease burden between ankylosing spondylitis (AS) and non-radiographic (nr) axial spondyloarthritis (axSpA) and establish a model that allows to identify high-cardiovascular (CV) risk in axial spondyloarthritis patients. METHODS: Cross-sectional study from the AtheSpAin cohort, a Spanish multicenter cohort aimed to study atherosclerosis in axSpA. Carotid ultrasound (US) was performed to determine the carotid intima-media wall thickness (cIMT) and detect the presence of carotid plaques. The European cardiovascular disease risk assessment model, the Systematic COronary Risk Evaluation (SCORE), was also applied. RESULTS: A set of 639 patients with AS and 167 patients with nr-axSpA without history of CV events were recruited. AS patients were older showing more CV risk factors and higher values of C reactive protein and erythrocyte sedimentation rate (ESR) than those with nr-axSpA. However, no difference in the prevalence of carotid plaques or in the cIMT was found between both groups in the adjusted analysis. The percentage of patients reclassified from the low and moderate CV risk categories to the very high-risk category due to the presence of carotid plaques was comparable in AS and nr-axSpA (10.7% versus 10.1% and 40.5% versus 45.5%, respectively). A model containing age, BASFI and ESR applied to moderate risk axSpA patients identified 41% of these patients as having very high-risk patients with high specificity (88%). CONCLUSION: The atherosclerosis burden is similar in nr-axSpA and AS. As occurred for AS, more than 40% of axSpA patients included in the category of moderate CV risk according to the SCORE are reclassified into very high risk after carotid US, and a clinically relevant proportion of them can be detected by applying a model containing age, BASFI and ESR.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. González Mazón I, Rueda-Gotor J, Ferraz-Amaro I, et al. Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients. Semin Arthritis Rheum. 2021. PMID: 33607385. doi:10.1016/j.semarthrit.2021.02.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。